Hand-foot syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with colorectal cancer confirmed by pathology; first-time use of medications containing oxaliplatin capecitabine etc.;Estimated survival time of more than 3 months aged; between 18 and 60 years; no severe skin diseases on the hands and feet such as severe eczema or infections; patients or their legal representatives voluntarily signed the informed consent form willing to participate in the study and cooperate to complete the entire research process.
Exclusion criteria
Exclusion criteria: Patients with other severe comorbidities such as severe heart liver or kidney dysfunction psychiatric disorders etc.; patients with known allergies to camellia oil or massage procedures; pregnant or lactating women; patients unwilling or unable to receive care and follow-up as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of Life;Incidence and severity of hand-foot syndrome; | — |
Countries
China
Contacts
Clinical Oncology School of Fujian Medical UniversityFujian Cancer Hospital